Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Theander

Showing results (151-160 of 329) with videos related to

Pageof 33
Sort By:
Immunology|August 1, 1993
Anti-phospholipid antibodies in patients with Plasmodium falciparum malariaP H Jakobsen, S D Morris-Jones, L Hviid, et al.
Vaccine|June 6, 2017
Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like displaySusheel K Singh, Susan Thrane, Christoph M Janitzek, et al.
The Journal of Infectious Diseases|November 14, 1997
The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivoM Chen, S Brøgger Christensen, L Zhai, et al.
FEMS Immunology and Medical Microbiology|May 5, 1998
The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. majorM Kemp, E Handman, K Kemp, et al.
Infection and Immunity|March 1, 1993
Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasisM Kemp, J A Kurtzhals, K Bendtzen, et al.
Malaria Journal|December 17, 2005
Rapid screening for glucose-6-phosphate dehydrogenase deficiency and haemoglobin polymorphisms in Africa by a simple high-throughput SSOP-ELISA methodAnders Enevold, Lasse S Vestergaard, John Lusingu, et al.
Vaccines|May 28, 2022
Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact DermatitisLouise Goksøyr, Anders B Funch, Anna K Okholm, et al.
Scandinavian Journal of Immunology|July 1, 1988
Cell-mediated immunity to Plasmodium falciparum infection: evidence against the involvement of cytotoxic lymphocytesT G Theander, B J Andersen, B K Pedersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
3D7-Derived Plasmodium falciparum erythrocyte membrane protein 1 is a frequent target of naturally acquired antibodies recognizing protein domains in a particular pattern independent of malaria transmission intensityLouise Joergensen, Lasse S Vestergaard, Louise Turner, et al.
The American Journal of Tropical Medicine and Hygiene|May 7, 2008
Reduced risk of uncomplicated malaria episodes in children with alpha+-thalassemia in northeastern TanzaniaAnders Enevold, John P Lusingu, Bruno Mmbando, et al.
Pageof 33

Showing results (151-160 of 329) with videos related to

Sort By:
Pageof 33
Immunology|August 1, 1993
Anti-phospholipid antibodies in patients with Plasmodium falciparum malariaP H Jakobsen, S D Morris-Jones, L Hviid, et al.
Vaccine|June 6, 2017
Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like displaySusheel K Singh, Susan Thrane, Christoph M Janitzek, et al.
The Journal of Infectious Diseases|November 14, 1997
The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivoM Chen, S Brøgger Christensen, L Zhai, et al.
FEMS Immunology and Medical Microbiology|May 5, 1998
The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. majorM Kemp, E Handman, K Kemp, et al.
Infection and Immunity|March 1, 1993
Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasisM Kemp, J A Kurtzhals, K Bendtzen, et al.
Malaria Journal|December 17, 2005
Rapid screening for glucose-6-phosphate dehydrogenase deficiency and haemoglobin polymorphisms in Africa by a simple high-throughput SSOP-ELISA methodAnders Enevold, Lasse S Vestergaard, John Lusingu, et al.
Vaccines|May 28, 2022
Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact DermatitisLouise Goksøyr, Anders B Funch, Anna K Okholm, et al.
Scandinavian Journal of Immunology|July 1, 1988
Cell-mediated immunity to Plasmodium falciparum infection: evidence against the involvement of cytotoxic lymphocytesT G Theander, B J Andersen, B K Pedersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
3D7-Derived Plasmodium falciparum erythrocyte membrane protein 1 is a frequent target of naturally acquired antibodies recognizing protein domains in a particular pattern independent of malaria transmission intensityLouise Joergensen, Lasse S Vestergaard, Louise Turner, et al.
The American Journal of Tropical Medicine and Hygiene|May 7, 2008
Reduced risk of uncomplicated malaria episodes in children with alpha+-thalassemia in northeastern TanzaniaAnders Enevold, John P Lusingu, Bruno Mmbando, et al.
Pageof 33